dijous, 18 de desembre del 2014

FDA OKs expedited enrollment for InVivo study




The FDA approves an expedited enrollment plan for a 5-patient pivotal study testing InVivo Therapeutics' neuro-spinal scaffold devices in the treatment of severe spinal cord injuries.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1AkjEt7

Cap comentari:

Publica un comentari a l'entrada